Wall Cardiovascular settles with Medtronic, Boston Sci

Wall Cardiovascular Technologies agreed to settlements with two of the four major drug-eluting stent makers it's accused of patent infringement, leaving Abbott and Johnson & Johnson subsidiary Cordis Corp. as the remaining defendants. Medtronic and Boston Scientific each agreed to settle with Wall, with all sides bearing their own legal costs. That leaves Cordis as the sole defendant in the first lawsuit; Abbott, the only defendant in the second lawsuit, also has yet to agree to a settlement. News

Suggested Articles

The immunoassay will measure neurofilament light chain protein levels, found in the blood and cerebrospinal fluid, and linked to nerve damage.

Emmecell aims to make corneal transplant surgery, which can take up to a year to heal from and fails up to 20% of the time, a relic of the past.

Seven developers will provide digital health solutions aimed at the COVID-19 pandemic, including smartphone apps, wearables and big data programs.